Cite
MLA Citation
A Dravid et al.. “Efficacy and safety of a single‐tablet regimen containing tenofovir disoproxil fumarate 300 mg, lamivudine 300 mg and efavirenz 400 mg as a switch strategy in virologically suppressed HIV‐1‐infected subjects on nonnucleoside reverse transcriptase inhibitor‐containing first‐line antiretroviral therapy in Pune, India.” HIV medicine, vol. 21, no. 9, 2020, pp. 578–587. http://access.bl.uk/ark:/81055/vdc_100110169374.0x000023